NUS — NU Skin Enterprises Cashflow Statement
0.000.00%
Last trade - 00:00- $646.13m
- $894.48m
- $1.97bn
- 87
- 88
- 32
- 78
Annual cashflow statement for NU Skin Enterprises, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 174 | 191 | 147 | 105 | 8.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 58.2 | 73.1 | 106 | 75.1 | 139 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -132 | 52.6 | -194 | -92.7 | -81.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 178 | 379 | 142 | 108 | 119 |
| Capital Expenditures | -66.1 | -63.8 | -68.6 | -59.1 | -58.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -5.34 | -15.6 | -20.1 | -8.02 | -76 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -71.4 | -79.4 | -88.7 | -67.1 | -135 |
| Financing Cash Flow Items | 0 | 0 | — | -5.08 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -155 | -245 | -105 | -99.5 | 10.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -51.3 | 67.1 | -63.1 | -74.9 | -8.67 |